Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 4/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.56 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.55 |
| ▸ | CHRND | Q07001 | 6/20 | 0.54 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.54 |
| ▸ | CHRNG | P07510 | 2/20 | 0.54 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.54 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4629789 | 1.00 | NAALAD2 (0.59) | NAALAD2ACEFOLH1MMEITGB3 | |
| SCHEMBL29885832 | 0.89 | ACE (0.63) | NAALAD2ACEMMEITGB3ITGA2B | |
| SCHEMBL1330423 | 0.89 | ACE (0.63) | NAALAD2ACEMMEITGB3ITGA2B | |
| SCHEMBL1330426 | 0.89 | ACE (0.63) | NAALAD2ACEMMEITGB3ITGA2B | |
| SCHEMBL10338342 | 0.89 | ITGB3 (0.66) | ITGB3ITGA2BCHRNDCHRNA1CHRNG | |
| SCHEMBL10338341 | 0.89 | ITGB3 (0.66) | ITGB3ITGA2BCHRNDCHRNA1CHRNG | |
| SCHEMBL479126 | 0.88 | ACE (0.60) | NAALAD2ACEFOLH1MMEITGB3 | |
| SCHEMBL3459805 | 0.88 | ACE (0.60) | NAALAD2ACEFOLH1MMEITGB3 | |
| SCHEMBL7110125 | 0.88 | ACE (0.60) | NAALAD2ACEFOLH1MMEITGB3 | |
| SCHEMBL479125 | 0.88 | ACE (0.60) | NAALAD2ACEFOLH1MMEITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61063692-A | — | — | None | — | — | JP | disclosed |
| US-12018049-B2 | Compositions and related methods for controlling vector-borne diseases | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20210360934-A1 | COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-11-25 | — | — | US | disclosed |
| US-20210275635-A1 | COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-09 | — | — | US | disclosed |
| US-20200261536-A1 | COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES | FLAGSHIP PIONEERING, INC. | 2020-08-20 | — | — | US | disclosed |
| CN-111225686-A | Treatment of inflammatory diseases using ingestible devices to release immunomodulators | 普罗根尼蒂公司 | 2020-06-02 | — | — | CN | disclosed |
| US-20200060286-A1 | COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2020-02-27 | — | — | US | disclosed |
| EP-3573638-A1 | COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES | Flagship Pioneering Innovations V, Inc. (US) | 2019-12-04 | — | — | EP | disclosed |
| CN-110430801-A | Treatment of gastrointestinal disorders using TNF inhibitors | PROGENITY INC | 2019-11-08 | — | — | CN | disclosed |
| CN-110402097-A | Gastrointestinal tract detection method, device and system | PROGENITY INC | 2019-11-01 | — | — | CN | disclosed |
| CN-110167589-A | Treatment of gastrointestinal disorders using integrin inhibitors | 普罗根尼蒂公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-110087530-A | Gastrointestinal tract detection method, device and system | 普罗根尼蒂公司 | 2019-08-02 | — | — | CN | disclosed |
| CN-110072519-A | Treatment of gastrointestinal disorders using JAK inhibitors and devices | 普罗根尼蒂公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-110072551-A | Treatment of gastrointestinal disorders using IL-12/IL-23 inhibitors released using ingestible devices | 普罗根尼蒂公司 | 2019-07-30 | — | — | CN | disclosed |
| US-20190216093-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING, INC. | 2019-07-18 | — | — | US | disclosed |
| WO-2018140507-A1 | COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES | FLAGSHIP PIONEERING, INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| WO-2018140518-A1 | COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES | FLAGSHIP PIONEERING, INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| WO-2018140519-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING, INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| JP-S6163692-A | NOVEL 2'-5' OLIGOADENYLIC ACID COMPOUND, PREPARATION THEREOF AND ANTIGEN FOR 125I-LABELING COMPOSED OF SAME USED FOR 2'5' OLIGOADENYLIC ACID MEASUREMENT BY RADIOIMMUNOASSAY | SAWAI HIROAKI | 1986-04-01 | — | — | JP | disclosed |